BG103714A - Лекарствена форма за гълтане, съдържаща парацетамол - Google Patents

Лекарствена форма за гълтане, съдържаща парацетамол

Info

Publication number
BG103714A
BG103714A BG103714A BG10371499A BG103714A BG 103714 A BG103714 A BG 103714A BG 103714 A BG103714 A BG 103714A BG 10371499 A BG10371499 A BG 10371499A BG 103714 A BG103714 A BG 103714A
Authority
BG
Bulgaria
Prior art keywords
pararacetamol
containing tablet
tablet
pharmaceutically acceptable
sodium bicarbonate
Prior art date
Application number
BG103714A
Other languages
English (en)
Other versions
BG64348B1 (bg
Inventor
James Grattan
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of BG103714A publication Critical patent/BG103714A/bg
Publication of BG64348B1 publication Critical patent/BG64348B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)

Abstract

Изобретението се отнася до таблетна или капсулна форма, съдържаща парацетамол, натриев бикарбонат ипоне един фармацевтично приемлив ексципиент. </P>
BG103714A 1997-03-05 1999-09-03 Лекарствена форма за гълтане, съдържаща парацетамол BG64348B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9704524.9A GB9704524D0 (en) 1997-03-05 1997-03-05 Composition

Publications (2)

Publication Number Publication Date
BG103714A true BG103714A (bg) 2000-05-31
BG64348B1 BG64348B1 (bg) 2004-11-30

Family

ID=10808717

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103714A BG64348B1 (bg) 1997-03-05 1999-09-03 Лекарствена форма за гълтане, съдържаща парацетамол

Country Status (36)

Country Link
US (1) US6316025B1 (bg)
EP (1) EP0981334B1 (bg)
JP (1) JP2001513801A (bg)
KR (1) KR100465895B1 (bg)
CN (1) CN100389751C (bg)
AP (1) AP1084A (bg)
AR (1) AR011919A1 (bg)
AT (1) ATE240720T1 (bg)
AU (1) AU721851B2 (bg)
BG (1) BG64348B1 (bg)
BR (1) BR9807992A (bg)
CA (1) CA2283408C (bg)
CO (1) CO4940406A1 (bg)
CY (1) CY2367B1 (bg)
CZ (1) CZ294078B6 (bg)
DE (1) DE69814850T2 (bg)
DK (1) DK0981334T3 (bg)
EA (1) EA001918B1 (bg)
ES (1) ES2199435T3 (bg)
GB (1) GB9704524D0 (bg)
HK (1) HK1027026A1 (bg)
HU (1) HU224983B1 (bg)
ID (1) ID22233A (bg)
IL (1) IL131552A (bg)
MY (1) MY119722A (bg)
NO (1) NO327456B1 (bg)
NZ (1) NZ337418A (bg)
PE (1) PE68899A1 (bg)
PL (1) PL190988B1 (bg)
PT (1) PT981334E (bg)
SK (1) SK282277B6 (bg)
TR (1) TR199902175T2 (bg)
TW (1) TW508242B (bg)
UA (1) UA59388C2 (bg)
WO (1) WO1998038983A2 (bg)
ZA (1) ZA981832B (bg)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
NZ508291A (en) * 1999-11-24 2002-09-27 Mcneil Ppc Inc Use of acetaminophen in a medicament for treating migraine symptoms
GB0006897D0 (en) * 2000-03-23 2000-05-10 Smithkline Beecham Plc Medicaments
GB0114069D0 (en) 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
GB0129117D0 (en) * 2001-12-05 2002-01-23 Glaxo Group Ltd Pharmaceutical composition
WO2004089365A1 (en) * 2003-04-11 2004-10-21 Pfizer Limited Pharmaceutical combination comprising eletriptan and sodium bicarbonate
US20080287456A1 (en) * 2004-05-28 2008-11-20 Imaginot Pty Ltd Oral Therapeutic Compound Delivery System
WO2005115344A1 (en) * 2004-05-28 2005-12-08 Imaginot Pty Ltd Oral delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
US20070298096A1 (en) * 2004-10-28 2007-12-27 Rong Liu Analgesic/Antipyretic Compositions for Enhanced Absorption
US9060950B2 (en) * 2005-06-13 2015-06-23 Paul H. Rosenberg, Proximate Concepts, LLC. Emetic embedded capsule
EP1893183A4 (en) * 2005-06-13 2010-08-18 Paul Rosenberg CAPSULE CONTAINING AN EMETIC
KR100702069B1 (ko) * 2005-10-31 2007-03-30 (주)이엘티사이언스 파라세타몰 경구용 수용산제 복합조성물 및 그 제조방법
AU2006317530B2 (en) 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
GB0607085D0 (en) 2006-04-07 2006-05-17 Smithkline Beecham Corp Novel compositions
EP2043613A1 (en) * 2006-07-14 2009-04-08 Fmc Corporation Solid form
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
CN101815513B (zh) * 2007-08-07 2012-11-14 斯泰伦博斯大学 含有对乙酰氨基苯酚的眼用制剂
KR101687580B1 (ko) 2016-07-19 2016-12-20 주식회사 씨.월드 의자 등받이부와 프레임부 조립구조
KR20210094513A (ko) 2018-11-19 2021-07-29 재즈 파마슈티칼즈 아일랜드 리미티드 알코올-내성 약물 제형

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1182049A (en) * 1981-07-13 1985-02-05 Francis J. Sterbenz Apap antacid composition
EP0377906B1 (en) * 1989-01-12 1993-12-15 Bayer Ag Effervescent analgesic antacid composition having reduced sodium content
US4942039A (en) * 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
US5348745A (en) * 1989-05-09 1994-09-20 Miles Inc. Aqueous granulation solution and a method of tablet granulation
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
DE19502789A1 (de) * 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel

Also Published As

Publication number Publication date
DE69814850D1 (de) 2003-06-26
JP2001513801A (ja) 2001-09-04
KR20000075897A (ko) 2000-12-26
NZ337418A (en) 2000-05-26
WO1998038983A3 (en) 1998-12-17
IL131552A (en) 2004-08-31
CZ294078B6 (cs) 2004-09-15
CZ314899A3 (cs) 2000-03-15
AU6828298A (en) 1998-09-22
US6316025B1 (en) 2001-11-13
AU721851B2 (en) 2000-07-13
CY2367B1 (en) 2004-06-04
CN1253497A (zh) 2000-05-17
SK119799A3 (en) 2000-02-14
ID22233A (id) 1999-09-23
NO994294D0 (no) 1999-09-03
DE69814850T2 (de) 2004-03-11
EP0981334A1 (en) 2000-03-01
EP0981334B1 (en) 2003-05-21
BR9807992A (pt) 2000-03-08
CO4940406A1 (es) 2000-07-24
HUP0001501A2 (hu) 2000-09-28
DK0981334T3 (da) 2003-09-22
MY119722A (en) 2005-07-29
ES2199435T3 (es) 2004-02-16
WO1998038983A2 (en) 1998-09-11
SK282277B6 (sk) 2002-01-07
PL190988B1 (pl) 2006-02-28
NO994294L (no) 1999-09-03
PE68899A1 (es) 1999-09-26
KR100465895B1 (ko) 2005-01-13
ZA981832B (en) 1998-12-11
AR011919A1 (es) 2000-09-13
ATE240720T1 (de) 2003-06-15
UA59388C2 (uk) 2003-09-15
NO327456B1 (no) 2009-07-06
IL131552A0 (en) 2001-01-28
HK1027026A1 (en) 2001-01-05
CA2283408C (en) 2007-01-02
AP9901638A0 (en) 1999-09-30
EA001918B1 (ru) 2001-10-22
HUP0001501A3 (en) 2001-01-29
CN100389751C (zh) 2008-05-28
BG64348B1 (bg) 2004-11-30
HU224983B1 (en) 2006-05-29
TW508242B (en) 2002-11-01
EA199900709A1 (ru) 2000-08-28
PT981334E (pt) 2003-10-31
PL335502A1 (en) 2000-04-25
TR199902175T2 (xx) 1999-12-21
GB9704524D0 (en) 1997-04-23
CA2283408A1 (en) 1998-09-11
AP1084A (en) 2002-07-23

Similar Documents

Publication Publication Date Title
BG103714A (bg) Лекарствена форма за гълтане, съдържаща парацетамол
EP0645136A3 (en) Pharmaceutical preparation of the type: physiologically active substance with sustained release.
ZA967745B (en) Pharmaceutical formulations.
ZA969722B (en) Pharmaceutical formulations.
PH31059A (en) Pharmaceutical compositions comprising cyclosporins.
HK1027966A1 (en) Pharmaceutical formulations containing voriconazole
GR3026758T3 (en) Lactobacillus strains of human origin, their compositions and uses thereof
DE69801369D1 (de) Peptidanaloge des lh-rh, ihre verwendungen und die sie enthaltenden pharmazeutischen zusammensetzungen
GR3032366T3 (en) Pharmaceutical cyclosporin composition.
PH30928A (en) Pharmaceutical agents.
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer&#39;s disease
IL110481A0 (en) 1-Benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them
PL331709A1 (en) Cytotoxic aminosaccharic and affinite saccharic derivatives of indolopyrrole carbazoles
HK1029290A1 (en) Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions.
BG104179A (bg) Използване на фанхинон за лечението на болестта на алцхаймер
GEP20063719B (en) Prevention of Migraine Recurrence
PT1131297E (pt) Certas caprolactamas substituidas composicoes farmaceuticas contendo-as e sua utilizacao no tratamento de tumores
HK1040488A1 (en) Pharmaceutical formulations.
ZA989536B (en) Medical face mask.
CA2185242A1 (en) Sustained release tablet containing diclofenac-na
BG106151A (bg) Фармацевтичен комплекс
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
BG106534A (bg) Разтвор за перорално приложение, съдържащ галантамин и подсладител
ZA966345B (en) Gas capsule.
MD1473G2 (ro) Remediu antiherpetic